EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,093,199 | +43.7% | 136,821 | +56.5% | 0.00% | – |
| Q2 2023 | $760,588 | +189.6% | 87,424 | -2.1% | 0.00% | – |
| Q1 2023 | $262,658 | +206.5% | 89,339 | +264.9% | 0.00% | – |
| Q4 2022 | $85,698 | +8.5% | 24,485 | +143.8% | 0.00% | – |
| Q3 2022 | $79,000 | -13.2% | 10,043 | -14.2% | 0.00% | – |
| Q2 2022 | $91,000 | -19.5% | 11,711 | +26.6% | 0.00% | – |
| Q1 2022 | $113,000 | -53.5% | 9,248 | -53.5% | 0.00% | – |
| Q4 2021 | $243,000 | +279.7% | 19,893 | +221.9% | 0.00% | – |
| Q3 2021 | $64,000 | -57.3% | 6,180 | -63.1% | 0.00% | – |
| Q2 2021 | $150,000 | +383.9% | 16,744 | +456.3% | 0.00% | – |
| Q1 2021 | $31,000 | +138.5% | 3,010 | +49.8% | 0.00% | – |
| Q4 2020 | $13,000 | – | 2,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |